amantadine and rimantadine

amantadine has been researched along with rimantadine in 292 studies

Research

Studies (292)

TimeframeStudies, this research(%)All Research%
pre-199054 (18.49)18.7374
1990's61 (20.89)18.2507
2000's95 (32.53)29.6817
2010's73 (25.00)24.3611
2020's9 (3.08)2.80

Authors

AuthorsStudies
Belshe, RB; Cerruti, RL; Connell, EV; Hill, CH; Keech, E; Manchand, PS; Martin, JA; Merrett, JH; Sim, IS1
Andrei, G; Balzarini, J; De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Neyts, J; Padalko, E; Snoeck, R1
De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Mavromoustakos, T; Tataridis, D1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
De Clercq, E; Foscolos, GB; Fytas, G; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingham, SR; Zoidis, G1
De Clercq, E; Gawin, R; Koszytkowska-Stawińska, M; Naesens, L1
Camins, A; Camps, P; Cortés, D; De Clercq, E; Duque, MD; Ivorra, D; Kelly, JM; López-Querol, M; Naesens, L; Pallàs, M; Prathalingam, SR; Romero, V; Sureda, FX; Vázquez, S1
De Clercq, E; Kolocouris, N; Naesens, L; Zoidis, G1
Camps, P; De Clercq, E; Duque, MD; Kelly, JM; López-Querol, M; Mallol, J; Montaner, S; Naesens, L; Prathalingam, SR; Profire, L; Sureda, FX; Vázquez, S1
Balzarini, J; Brancale, A; Cirilli, R; Coluccia, A; Giordano, C; La Regina, G; La Torre, F; Lavecchia, A; Maga, G; Novellino, E; Piscitelli, F; Samuele, A; Sansone, A; Silvestri, R; Zanoli, S1
Batta, G; Herczegh, P; Kéki, S; Komáromi, I; Mándi, A; Naesens, L; Ostorházi, E; Pintér, G; Röth, E; Rozgonyi, F; Sztaricskai, F; Takács-Novák, K1
Camins, A; Camps, P; Duque, MD; Kelly, JM; López-Querol, M; Prathalingam, SR; Sureda, FX; Torres, E; Valverde, E; Vázquez, S1
Batta, G; Bereczki, I; Boda, Z; Herczegh, P; Naesens, L; Ostorházi, E; Otvös, R; Pintér, G; Roth, E; Rozgonyi, F; Szarvas, M; Sztaricskai, F1
Eleftheratos, S; Hay, A; Kolocouris, A; Martin, S; Martinelli, A; Ortore, G; Spearpoint, P1
De Clercq, E; Ganguly, S; Kumar, KS; Veerasamy, R1
De Clercq, E; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingam, SR; Zoidis, G1
Balzarini, J; De Clercq, E; Dewan, SK; Kumar, P; Narasimhan, B; Pannecouque, C; Yadav, S1
Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D1
Duque, MD; Kelly, JM; López-Querol, M; Ma, C; Naesens, L; Pinto, LH; Sureda, FX; Taylor, MC; Torres, E; Vázquez, S1
Balzarini, J; Bharatam, PV; Chibale, K; Kaur, H; Little, S; Singh, K1
Batta, G; Bereczki, I; Borbás, A; Fejes, Z; Herczegh, P; Kiss-Szikszai, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Török, Z1
Cesur, N; Cesur, Z; Göktaş, F; Naesens, L; Vanderlinden, E1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA1
Canturk, B; DeGrado, WF; Fiorin, G; Jo, H; Klein, ML; Lamb, RA; Ma, C; Pinto, LH; Wang, J1
Balzarini, J; Chibale, K; Kaur, H; Singh, K1
Balzarini, J; Singh, K1
Barniol-Xicota, M; DeGrado, WF; Lamb, RA; Ma, C; Naesens, L; Pinto, LH; Rey-Carrizo, M; Torres, E; Vázquez, S; Wang, J; Wu, Y1
Busath, DD; Cross, TA; Fedida, D; Johnson, FB; Kolocouris, A; Tietjen, I; Tzitzoglaki, C; Wright, AK; Zell, R1
Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S1
Batta, G; Bereczki, I; Borbás, A; Dobray, L; Herczegh, P; Kéki, S; Kicsák, M; Naesens, L; Nikodém, ÉN; Ostorházi, E; Rozgonyi, F; Vanderlinden, E1
Batta, G; Bereczki, I; Borbás, A; Fizil, Á; Herczegh, P; Komáromi, I; Kurtán, T; Mándi, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Sztaricskai, F; Vanderlinden, E1
Font-Bardia, M; Frigolé-Vivas, M; Gazzarrini, S; Juárez-Jiménez, J; Llabrés, S; Luque, FJ; Moroni, A; Naesens, L; Rey-Carrizo, M; Vázquez, S1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chizhov, AO; Geisman, AN; Khandazhinskaya, AL; Kochetkov, SN; Naesens, L; Novikov, MS; Ozerov, AA; Pannecouque, C; Seley-Radtke, KL; Valuev-Elliston, VT1
Artyushin, OI; Brel, VK; Genkina, GK; Kadyrova, RA; Klemenkova, ZS; Moiseeva, AA; Orshanskaya, IR; Salakhutdinov, NF; Sharova, EV; Shtro, AA; Vinogradova, NM; Yarovaya, OI; Zarubaev, VV1
Barniol-Xicota, M; Gazzarrini, S; Hu, Y; Moroni, A; Naesens, L; Torres, E; Vázquez, S; Wang, J1
Cichero, E; Costi, MP; Gazzarrini, S; Loddo, R; Moroni, A; Naesens, L; Santucci, M; Tasso, B; Tonelli, M1
Busath, DD; Drakopoulos, A; Freudenberger, K; Gauglitz, G; Hoffmann, A; Hutterer, J; Kolocouris, A; Kolokouris, D; Konstantinidi, A; Ma, C; McGuire, K; Schmidtke, M; Tzitzoglaki, C; Wang, J1
Andrei, G; Pertusati, F; Pileggi, E; Schols, D; Serpi, M; Snoeck, R1
Cichero, E; Costi, MP; Francesconi, V; Giordanetto, F; Giovannini, L; Naesens, L; Santucci, M; Tonelli, M1
Orshanskaya, IR; Salakhutdinov, NF; Semenova, MD; Shtro, AA; Sokolova, AS; Yarovaya, OI; Zarubaev, VV1
Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E1
Bormotov, NI; Dorovatovskii, PV; Gatilov, YV; Khrustalev, VN; Kovaleva, KS; Novikov, RA; Salakhutdinov, NF; Shishkina, LN; Yarovaya, OI; Zarubaev, VV; Zubkov, FI1
Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K1
Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V1
Borisevich, SS; Lantseva, K; Mainagashev, IY; Salakhutdinov, NF; Shtro, AA; Sokolova, AS; Volobueva, AS; Yarovaya, OI; Zarubaev, VV1
Balzarini, J; De Clercq, E; Karki, SS; Kulkarni, AA; Kumar, S; Veliyath, SK1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Longuet, P; Vildé, JL1
Arden, NH; Monto, AS1
Bruu, AL; Orstavik, I1
Grambas, S; Hay, AJ1
Drinka, P; Gravenstein, S; Miller, BA1
Hay, AJ; Hayden, FG1
Newell, PM; Van Voris, LP1
Douglas, RG2
Hayden, FG8
Gilbert, BE; Knight, V1
Bean, B1
Bryson, YJ1
Johnson, DC1
Steele, RW1
Bricaire, F1
Betts, RF1
Belshe, RB; Burk, B; Cerruti, RL; Newman, F; Sim, IS1
Dolin, R1
Donath, E; Donath, J; el-Karadagi, S; Glaser, R; Herrmann, A; Kharitonenkov, IG; Lentzsch, P; Tverdislov, VA1
Coakley, WT; Donath, E; Egger, M; Groth, T; Herrmann, A; Taeger, M1
Donath, E; Egger, M; Glaser, R; Ziemer, S1
Uhl, D1
Blasecki, JW; Gaylord, JC; Hoffman, HE; Shalaby, LM; Whitney, CC1
Hayden, FG; Tominack, RL1
Spector, R1
Cockerill, FR; Hermans, PE1
Jannasch, R1
Bean, WJ; Kawaoka, Y; Webster, RG1
Hayden, FG; Hoffman, HE; Minocha, A; Spyker, DA1
Galbraith, AW1
Bean, WJ; Beard, CW; Brugh, M; Kawaoka, Y; Webster, RG1
La Force, FM1
Döhner, L; Mentel, R; Panzig, B; Seidel, W1
Adamczyk, B; Heider, H; Richter, B1
Adamczyk, B; Feldblum, R; Heider, H; Indulen, MK; Presber, HW; Schroeder, C1
Nicholson, KG3
Galasso, GJ1
Yaar, I1
White, DO1
Togo, Y1
Pert, CB; Quirion, R1
Goldwater, PN1
Field, HJ; Oxford, JS1
Bucher, DJ; El Karadaghi, S; Kharitonenkov, IG; Tverdislov, VA; Zakomirdin, JA1
Valenti, WM1
Sebastiani, A1
Garcia Gil, M; Sanchez Crespo, M1
Hayden, FG; Hoffman, HE; Spyker, DA1
Betts, RF; Christmas, WA; Douglas, RG; Hayden, FG; Van Voris, LP1
Bryson, YJ; Dreisbach, M; Millet, VM1
Kramer, MJ; Tilley, JW1
Dolin, R; Linton, PN; Madore, HP; Maynard, R; Reichman, RC; Webber-Jones, J1
Burlington, DB; Meiklejohn, G; Mostow, SR2
Hovi, T1
Cate, TR; Couch, RB; Goswick, CB; Quarles, JM1
Adams, KF; Giordani, B; Gwaltney, JM; Hayden, FG; Van de Castle, RL1
Cote, KM; Douglas, RG; Hayden, FG1
Ford, CM; Hay, AJ; Schroeder, C; Wharton, SA1
Pyhälä, R1
Nahata, MC; Wintermeyer, SM1
Bandy, U1
Kuritzky, L1
Cordier, JF; Philit, F1
Cox, N; Hemphill, M; Hirsh, D; Houck, P; LaCroix, S1
Serkedjieva, J; Zgorniak-Nowosielska, I1
Guay, DR1
Monto, AS3
Morris, DJ1
Rakestraw, D1
Mahmood, W; Sacks, SL1
Ahwesh, ER; Ruben, FL; Zimmerman, RK1
Couch, RB2
Shigeta, S1
Merchant, GL; Mower, WR; Talan, DA1
Drinka, PJ; Gravenstein, S; Krause, P; Miller, BA; Schilling, M; Shult, P1
Margo, KL; Shaughnessy, AF1
Gerstoft, J; Pedersen, C1
Hayden, FG; Perelson, AS; Stilianakis, NI1
Niederman, MS1
Krapivin, SV; Morozov, IS; Sergeeva, SA1
Atmar, RL; Champlin, RE; Cox, NJ; Englund, JA; Kantarjian, H; Klimov, AI; Regnery, H; Tarrand, J; Whimbey, E; Wyde, PR; Yousuf, H1
Scholtissek, C; Webster, RG1
Expósito Rivas, L; Goyenechea Hernández, A; Pérez Rodríguez, AE; Rodríguez Leyva, O1
Mossad, SB2
Silagy, CA1
Reina, J1
Perrillo, RP; Younossi, ZM1
Ikejima, H; Kanemitsu, K; Shimada, J1
Deeks, J; Demicheli, V; Jefferson, T; Rivetti, D2
Butkiewicz, N; Hong, Z; Howe, AY; Jubin, R; Lau, JY; Murray, MG1
Goldman, MP; Long, JK; Mossad, SB1
Deeks, JJ; Demicheli, V; Jefferson, TO; Rivetti, D3
Bertino, JS; Karl, M; Keyser, LA; Nafziger, AN1
Ashley, JV; Gum, KD; Montalto, NJ1
Rosen, DS1
Fleming, DM1
Bennett, M; Cameron, K; Cox, N; Gregory, V; Hall, H; Hay, A; Klimov, A; Lim, W; Lin, YP; Marozin, S1
Hartshorn, KL; Kandel, R1
Preboth, M1
Holdiness, MR1
Gross, PA1
Havel, J; Pazourek, J; Polásková, P; Reichová, N1
Johnston, SL1
Farr, BM; Hall, KK; Hayden, FG; Salgado, CD1
Cox, NJ; Fukuda, K; Uyeki, TM1
Bridges, CB; Cox, NJ; Fukuda, K; Singleton, JA; Uyeki, TM1
Prober, CG1
Englund, JA1
Carman, WF; Kerr, G; Stott, DJ1
Uyeki, T; Winquist, A2
Basler, CF; García-Sastre, A; Mikulasova, A; Palese, P; Swayne, DE; Taubenberger, JK; Tumpey, TM1
Dumyati, G; Falsey, AR1
Balasingam, S; Bossuyt, S; Lambkin, R; Mann, A; Novelli, P; Oxford, JS1
Mitamura, K1
Kirkbride, HA; Watson, J1
Bellantonio, S; Rose, DN; Rothberg, MB1
Marra, CA; Marra, F; Stiver, HG1
Pegram, PS; Williamson, JC1
Lu, Q1
Härtl, A; Sauerbrei, A; Stelzner, A; Wutzler, P1
Baddour, LM; Prabhu, RM; Smith, TF; Trampuz, A1
Deeks, JJ; Demicheli, V; Jefferson, T; Rivetti, D; Rudin, M1
Fagan, HB; Moeller, AH1
Hansen, L2
Drew, WL1
Fujii, Y; Higashi, Y; Uemori, I1
Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C1
Fujii, Y; Higashi, Y1
Brandstaedt, A; Haertl, A; Sauerbrei, A; Schmidtke, M; Wutzler, P1
Fujii, Y; Higashi, Y; Matsumura, H; Nakamura, S1
Nau, JY1
Demicheli, V; Di Pietrantonj, C; Jefferson, T; Rivetti, D1
Chen, H; Cheung, CL; Guan, Y; Naipospos, TS; Peiris, JS; Rayner, JM; Smith, GJ; Wang, P; Webster, RG; Yuen, KY; Zhang, J1
De Clercq, E1
Cunha, BA1
Hayden, FG; Pavia, AT1
Brydak, LB; Gawryluk, D; Machała, M; Wiatr, E1
Lynch, JP; Walsh, EE1
Fang, F; Han, L; Ming, M; Shuangjin, C1
Bright, RA; Cox, NJ; Deyde, VM; Gubareva, LV; Klimov, AI; Shaw, M; Shu, Y; Smith, CB; Xu, X; Zhang, Y1
Wesseling, G1
Alves da Cunha, AJ; Alves Galvão, MG; Rocha Crispino Santos, MA3
Kelly, JM; Kolocouris, N; Papanastasiou, I; Prathalingam, SR; Tsotinis, A1
Worrall, G1
Nüesch, R1
Aruksakunwong, O; Chuenpennit, K; Decha, P; Hannongbua, S; Intharathep, P; Kaiyawet, N; Laohpongspaisan, C; Loisruangsin, A; Malaisree, M; Pianwanit, S; Rungrotmongkol, T; Sompornpisut, P1
Cameron, NA; Eggers, RR; Feldman, C; Green, RJ; Klugman, K; Lalloo, U; Madhi, SA; Phillips, D; Richards, GA; Schoub, B; Zar, HJ1
De Clercq, E; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingam, SR; Tsotinis, A; Zoidis, G1
Griffin, S; Harris, M; Owsianka, AM; Patel, AH; Rowlands, D; Stgelais, C1
Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B1
Chou, KC; Du, QS; Huang, RB; Li, XM; Wang, CH1
Banerjee, A; Eckels, PC; England, KM; Gamboni-Robertson, F; Gries, LM; Kelher, MR; Khan, SY; McLaughlin, NJ; Moore, EE; Silliman, CC1
Oxford, JS1
Trémolières, F1
Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD1
Dal Peraro, M; Devane, RH; Khurana, E; Klein, ML1
Arkin, IT; Astrahan, P1
Azad, TM; Gregory, V; Hay, A; Lin, YP; Yavarian, J; Zheng, X1
Griffin, S; Harris, M; Lemon, SM; Rowlands, D; Weinman, SA; Wozniak, AL; Yi, M1
Arkin, IT; Astrahan, P; Bennett, ER; Flitman-Tene, R; Gilon, C; Krugliak, M1
Chou, JJ; Pielak, RM1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ1
Arkin, IT; Astrahan, P; Krugliak, M; Leonov, H1
Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S1
Al-Najjar, BO; Choi, SB; Le, L; Tran, L; Wahab, HA; Yusuf, M1
Charman, SA; Couraud, PO; Kooijmans, SA; Mezhiselvam, MM; Morizzi, J; Nicolazzo, JA; Romero, IA; Senyschyn, D; Weksler, B1
Akl, EA; Alonso-Coello, P; Brozek, J; Chen, YL; Cheung, A; Flottorp, SA; Hopkins, JP; Hovhannisyan, G; Hsu, J; Ivanova, L; Mustafa, R; Saeterdal, I; Santesso, N; Schünemann, HJ; Smaill, F; Tian, J; Uyeki, TM; Wong, AD1
Chang, YX; Du, LM; Jing, X; Li, JF; Qin, YF; Wang, GQ; Wu, H1
Chen, YC; Chen, YW; Chu, CC; Hung, CH; Wang, JJ1
Li, G; Shen, H; Zhang, M; Zhang, Y1
Chen, J; Klibanov, AM; Larson, AM1
Cui, F; Ding, S; Li, J; Liu, X; Yan, H; Yang, D; Yun, H; Zhang, Z1
Król, E; Rychłowska, M; Szewczyk, B1
Leong, NJ; Mcintosh, MP; Prankerd, RJ; Shackleford, DM1
Li, F; Ma, C; Wang, J1
Peiris, JS; Perera, HK1
Le, LT; Nguyen, HT; Van Nguyen, H1
Bhardwaj, N; Fernandez, MV; Gopal, R; Greenbaum, BD; Krammer, F; Miller, E1
Fry, AM; McKimm-Breschkin, JL1
Chen, X; Fan, J; Li, Y; Lin, T; Liu, H; Liu, X1
Ali, NKM; Breitinger, HA; Breitinger, U; Farag, NS1
Qian, M; Wang, W; Xiao, C; Xu, J; Yang, H; Zhang, Q1
Chen, D; Dai, M; Liu, Z; Pan, Y; Peng, D; Wang, X; Wang, Y; Wei, W; Yuan, Z1
Chen, D; Miao, H; Wu, Y; Zhao, Y1
Gilson, MK; Henriksen, NM; Kantonen, SA1
Jia, Q; Li, D; Qian, Y; Qiu, J; Wang, X; Yang, S1
Guo, QY; Huang, DL; Tian, CL; Wang, ZA; Zhang, LH; Zheng, JS; Zuo, C1
Boeckler, FM; Breitinger, HG; Breitinger, U; Ma, C; Mandour, YM; Wang, J; Zlotos, DP1
Busath, DD; Hill, JT; McGuire, KL1
Ahmed, M; Ali, NKM; Breitinger, HG; Breitinger, U; El-Azizi, MA; Farag, NS1
Liu, JX; Wang, JP; Wu, NP; Zhang, L; Zhang, T1
Bukh, J; Fahnøe, U; Galli, A; Gammeltoft, KA; Gottwein, JM; Offersgaard, A; Ramirez, S; Zhou, Y1
B Andreas, L; Becker, S; Bentzen, BH; Giller, K; Jeppesen, MG; Kledal, TN; Kolocouris, A; Mujezinovic, A; Rosenkilde, MM; Toft-Bertelsen, TL; Tzortzini, E; Xue, K1
Kanda, T; Kogure, H; Moriyama, M; Okamoto, H; Sasaki-Tanaka, R; Shibata, T1
Chen, Y; Ma, J; Zhang, M; Zhao, Y1
Barchanska, H; Kostina-Bednarz, M; Płonka, J1

Reviews

92 review(s) available for amantadine and rimantadine

ArticleYear
The many faces of the adamantyl group in drug design.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility

2011
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advancements in mechanistic studies and structure activity relationship of F
    European journal of medicinal chemistry, 2019, Nov-15, Volume: 182

    Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship

2019
Implications of viral resistance to amantadine in control of influenza A.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:2

    Topics: Amantadine; Drug Resistance, Microbial; Humans; Influenza, Human; Rimantadine

1992
Prevention and control of influenza A outbreaks in long-term care facilities.
    Infection control and hospital epidemiology, 1992, Volume: 13, Issue:1

    Topics: Amantadine; Disease Outbreaks; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Long-Term Care; Rimantadine

1992
Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.
    Current topics in microbiology and immunology, 1992, Volume: 176

    Topics: Amantadine; Animals; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Rimantadine; Virulence

1992
Prophylaxis and treatment of influenza.
    The New England journal of medicine, 1990, Feb-15, Volume: 322, Issue:7

    Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine

1990
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
    Antiviral research, 1985, Volume: Suppl 1

    Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases

1985
Chemotherapy of respiratory viruses.
    Advances in internal medicine, 1986, Volume: 31

    Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases

1986
Respiratory pharmacology. Antiviral agents.
    Clinics in chest medicine, 1986, Volume: 7, Issue:3

    Topics: Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpesviridae Infections; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Vidarabine

1986
Antiviral agents for respiratory infections.
    The Pediatric infectious disease journal, 1988, Volume: 7, Issue:6

    Topics: Amantadine; Antiviral Agents; Child; Humans; Interferons; Respiratory Tract Infections; Ribavirin; Rimantadine; Virus Diseases

1988
Amantadine and rimantadine for the prevention of influenza A.
    Seminars in respiratory infections, 1989, Volume: 4, Issue:4

    Topics: Adamantane; Adult; Age Factors; Aged; Amantadine; Child; Humans; Influenza A virus; Influenza, Human; Rimantadine; Seasons; United States

1989
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
    Infectious disease clinics of North America, 1987, Volume: 1, Issue:2

    Topics: Adamantane; Adult; Aged; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine

1987
Influenza--recent developments in prophylaxis and treatment.
    British medical bulletin, 1985, Volume: 41, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Administration, Oral; Aerosols; Amantadine; Humans; Influenza, Human; Interferon Type I; Phosphatidylethanolamines; Ribavirin; Rimantadine

1985
Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
    Lancet (London, England), 1984, Sep-15, Volume: 2, Issue:8403

    Topics: Acyclovir; Adult; Amantadine; Antiviral Agents; Child; Female; Herpes Genitalis; Humans; Idoxuridine; Infant; Infant, Newborn; Influenza, Human; Keratitis, Dendritic; Male; Picornaviridae Infections; Recurrence; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Trifluridine; Vidarabine

1984
An assessment of antiviral drugs for the management of infectious diseases in humans.
    Antiviral research, 1981, Volume: 1, Issue:2

    Topics: Amantadine; Antiviral Agents; Ascorbic Acid; Dosage Forms; Drug Evaluation; Encephalitis; Hepatitis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Inosine Pranobex; Interferons; Levamisole; Rimantadine; Subacute Sclerosing Panencephalitis; Trifluridine; Virus Diseases

1981
Antiviral drugs 1983.
    The Medical clinics of North America, 1983, Volume: 67, Issue:5

    Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine

1983
Antiviral chemotherapy.
    The Medical journal of Australia, 1984, Jun-09, Volume: 140, Issue:12

    Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Bromodeoxyuridine; Female; Hepatitis B; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; In Vitro Techniques; Interferons; Male; Neoplasms; Papillomaviridae; Respiratory Tract Infections; Ribavirin; Rimantadine; Tumor Virus Infections; Vidarabine

1984
[Future of antifungal and antiviral agents. 2. Antiviral agents. b. Present status of chemotherapy of viral infections of the respiratory tract].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:3

    Topics: Amantadine; Antiviral Agents; Humans; Interferons; Respiratory Tract Infections; Ribavirin; Rimantadine; Virus Diseases

1984
Properties of antiviral agents. 2.
    Lancet (London, England), 1984, Sep-08, Volume: 2, Issue:8402

    Topics: Amantadine; Antiviral Agents; DNA Viruses; Female; Humans; Interferons; Ribavirin; Rimantadine; RNA Viruses; Virus Diseases

1984
Antiviral drugs today.
    The New Zealand medical journal, 1984, Dec-12, Volume: 97, Issue:769

    Topics: Acyclovir; Administration, Topical; Adolescent; Amantadine; Antiviral Agents; Chickenpox; Child; Clinical Trials as Topic; Encephalitis; Female; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Keratitis, Dendritic; Male; Rimantadine; Vidarabine

1984
Aminoadamantane derivatives.
    Progress in medicinal chemistry, 1981, Volume: 18

    Topics: Amantadine; Animals; Antiviral Agents; Humans; Memantine; Nervous System Diseases; Rimantadine

1981
[Amantadine, rimantadine and influenza].
    Duodecim; laaketieteellinen aikakauskirja, 1993, Volume: 109, Issue:19

    Topics: Amantadine; Humans; Influenza A virus; Ion Channels; Rimantadine; Viral Matrix Proteins

1993
Rimantadine: a clinical perspective.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:3

    Topics: Absorption; Amantadine; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Liver Diseases; Rimantadine

1995
Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.
    Drugs & aging, 1994, Volume: 5, Issue:1

    Topics: Aged; Amantadine; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Nursing Homes; Rimantadine

1994
Using antiviral agents to control outbreaks of influenza A infection.
    Geriatrics, 1994, Volume: 49, Issue:12

    Topics: Aged; Amantadine; Disease Outbreaks; Homes for the Aged; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Nursing Homes; Rimantadine; Seasons

1994
Adverse effects and drug interactions of clinical importance with antiviral drugs.
    Drug safety, 1994, Volume: 10, Issue:4

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine

1994
Viral respiratory infections in the community: epidemiology, agents, and interventions.
    The American journal of medicine, 1995, Dec-29, Volume: 99, Issue:6B

    Topics: Adolescent; Adult; Age Factors; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Orthomyxoviridae; Picornaviridae Infections; Respiratory Tract Infections; Rhinovirus; Rimantadine; Virus Diseases

1995
Anti-infective therapy for viral pneumonia.
    Seminars in respiratory infections, 1995, Volume: 10, Issue:4

    Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine

1995
Use of antivirals in influenza in the elderly: prophylaxis and therapy.
    Gerontology, 1996, Volume: 42, Issue:5

    Topics: Aged; Amantadine; Antiviral Agents; Disease Outbreaks; Humans; Influenza, Human; Orthomyxoviridae; Rimantadine; Risk Factors; Treatment Outcome; Virus Replication

1996
Antivirals for pandemic influenza.
    The Journal of infectious diseases, 1997, Volume: 176 Suppl 1

    Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Neuraminidase; Ribavirin; Rimantadine

1997
Influenza, influenza vaccine, and amantadine/rimantadine.
    The Journal of family practice, 1997, Volume: 45, Issue:2

    Topics: Amantadine; Antiviral Agents; Contraindications; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccination

1997
[Current status of research and development for anti-influenza virus drugs--chemotherapy for influenza].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:10

    Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Quinolizines; Rimantadine

1997
Update on emerging infections from the Centers for Disease Control and Prevention. Influenza: ED considerations for the 1997-98 season.
    Annals of emergency medicine, 1997, Volume: 30, Issue:5

    Topics: Amantadine; Antiviral Agents; Emergency Medicine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine

1997
Antiviral drugs in healthy children.
    American family physician, 1998, Mar-01, Volume: 57, Issue:5

    Topics: Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Child; Child, Preschool; Drug Administration Schedule; Herpes Simplex; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Rimantadine; Virus Diseases

1998
Strategies for prevention of community-acquired pneumonia.
    Seminars in respiratory infections, 1998, Volume: 13, Issue:1

    Topics: Amantadine; Antiviral Agents; Community-Acquired Infections; Humans; Influenza Vaccines; Influenza, Human; Pneumonia; Rimantadine; Staphylococcal Vaccines

1998
Underused options for preventing and treating influenza.
    Cleveland Clinic journal of medicine, 1999, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir

1999
[Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1999, Volume: 12, Issue:1

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Ribavirin; Rimantadine

1999
The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C.
    Seminars in liver disease, 1999, Volume: 19 Suppl 1

    Topics: Amantadine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Rimantadine; RNA, Viral; Treatment Outcome; Ursodeoxycholic Acid

1999
[Neurotoxicity of antiviral agents].
    Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2

    Topics: Acyclovir; Amantadine; Antiviral Agents; Central Nervous System Diseases; Ganciclovir; Humans; Rimantadine; Vidarabine

1999
Prevention and early treatment of influenza in healthy adults.
    Vaccine, 2000, Jan-06, Volume: 18, Issue:11-12

    Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2000
Measures for control of influenza.
    PharmacoEconomics, 1999, Volume: 16 Suppl 1

    Topics: Amantadine; Amines; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

1999
Cochrane reviews and systematic reviews of economic evaluations. Amantadine and rimantadine in the prevention and treatment of influenza.
    PharmacoEconomics, 1999, Volume: 16 Suppl 1

    Topics: Adult; Amantadine; Antiviral Agents; Cost of Illness; Humans; Influenza, Human; Rimantadine; United Kingdom

1999
Antiviral agents for treating influenza.
    Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:2

    Topics: Acetamides; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2000
Amantadine and rimantadine for preventing and treating influenza A in adults.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Rimantadine

2000
Prevention and treatment of influenza in immunocompromised patients.
    The American journal of medicine, 1997, Mar-17, Volume: 102, Issue:3A

    Topics: Aerosols; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Infusions, Intravenous; Organ Transplantation; Orthomyxoviridae; Primary Prevention; Ribavirin; Rimantadine

1997
Updated treatment for influenza A and B.
    American family physician, 2000, Dec-01, Volume: 62, Issue:11

    Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir

2000
Managing influenza: amantadine, rimantadine and beyond.
    International journal of clinical practice, 2001, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2001
Amantadine and rimantadine for preventing and treating influenza A in adults.
    The Cochrane database of systematic reviews, 2001, Issue:2

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine

2001
Prophylaxis and treatment of influenza virus infection.
    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001, Volume: 15, Issue:5

    Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Neuraminidase; Orthomyxoviridae Infections; Rimantadine; Vaccination

2001
Adverse cutaneous reactions to influenza vaccinations and chemotherapy.
    International journal of dermatology, 2001, Volume: 40, Issue:7

    Topics: Acetamides; Amantadine; Antiviral Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Skin; Zanamivir

2001
Vaccines for pneumonia and new antiviral therapies.
    The Medical clinics of North America, 2001, Volume: 85, Issue:6

    Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir

2001
Perspectives on antiviral use during pandemic influenza.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2001, Dec-29, Volume: 356, Issue:1416

    Topics: Acetamides; Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Multiple, Viral; Drug Tolerance; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2001
Anti-influenza therapies.
    Virus research, 2002, Jan-30, Volume: 82, Issue:1-2

    Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Neuraminidase; Rimantadine

2002
Influenza in the acute hospital setting.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:3

    Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir

2002
Antiviral therapy for influenza virus infections.
    Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1

    Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Global Health; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2002
Antiviral therapy of influenza.
    Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:2

    Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Guanidines; Humans; Infant; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2002
Amantadine and rimantadine for preventing and treating influenza A in adults.
    The Cochrane database of systematic reviews, 2002, Issue:3

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine

2002
Nosocomial transmission of influenza.
    Occupational medicine (Oxford, England), 2002, Volume: 52, Issue:5

    Topics: Aged; Amantadine; Antiviral Agents; Cross Infection; Health Personnel; Humans; Influenza Vaccines; Influenza, Human; Long-Term Care; Rimantadine

2002
Influenza.
    Clinical evidence, 2002, Issue:7

    Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir

2002
Antivirals for influenza: what is their role in the older patient?
    Drugs & aging, 2002, Volume: 19, Issue:10

    Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2002
Reduction of the influenza burden in children.
    Pediatrics, 2002, Volume: 110, Issue:6

    Topics: Adolescent; Adult; Amantadine; Child; Comorbidity; Cost of Illness; Evidence-Based Medicine; Female; Humans; Immunization Schedule; Infant; Influenza Vaccines; Influenza, Human; Length of Stay; Neuraminidase; Otitis Media; Pneumonia, Pneumococcal; Pregnancy; Rimantadine; United States

2002
Influenza.
    Clinical evidence, 2002, Issue:8

    Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Humans; Influenza, Human; Rimantadine; Sialic Acids

2002
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:1

    Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Endemic Diseases; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir

2003
[Antiviral agents for influenza].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir

2003
Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
    Communicable disease and public health, 2003, Volume: 6, Issue:2

    Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Health Planning; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2003
A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
    Canadian respiratory journal, 2003, Volume: 10, Issue:7

    Topics: Amantadine; Antiviral Agents; Canada; Data Interpretation, Statistical; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine

2003
Neuraminidase inhibitors in patients with underlying airways disease.
    American journal of respiratory medicine : drugs, devices, and other interventions, 2002, Volume: 1, Issue:2

    Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir

2002
Avian influenza: a new pandemic threat?
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:4

    Topics: Amantadine; Animals; Antiviral Agents; Asia; Communicable Diseases, Emerging; Disease Outbreaks; Drug Resistance, Multiple, Viral; Family Characteristics; Forecasting; Global Health; Humans; Influenza A virus; Influenza in Birds; Mutation; Neuraminidase; Patient Isolation; Population Surveillance; Poultry; Poultry Diseases; Recombination, Genetic; Rimantadine; Vaccination; Zoonoses

2004
Amantadine and rimantadine for preventing and treating influenza A in adults.
    The Cochrane database of systematic reviews, 2004, Issue:3

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine

2004
What is the best antiviral agent for influenza infection?
    American family physician, 2004, Oct-01, Volume: 70, Issue:7

    Topics: Acetamides; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Contraindications; Evidence-Based Medicine; Family Practice; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2004
Influenza.
    Clinical evidence, 2003, Issue:10

    Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2003
Pandemic influenza: is an antiviral response realistic?
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:11 Suppl

    Topics: Amantadine; Antiviral Agents; Disaster Planning; Disease Outbreaks; Drug Resistance, Viral; Health Services Accessibility; Humans; Influenza, Human; Rimantadine; United States

2004
Influenza.
    Clinical evidence, 2004, Issue:12

    Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2004
Amantadine and rimantadine for influenza A in adults.
    The Cochrane database of systematic reviews, 2006, Apr-19, Issue:2

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Emergencies; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine; Virus Shedding

2006
Which agents should we use to treat and prevent influenza in 2006-2007?
    Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:11

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir

2006
Antiviral therapy and prophylaxis for influenza in children.
    Pediatrics, 2007, Volume: 119, Issue:4

    Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir

2007
Influenza: evolving strategies in treatment and prevention.
    Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:2

    Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir

2007
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.
    International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:1

    Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir

2007
Amantadine and rimantadine for influenza A in children and the elderly.
    The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1

    Topics: Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors

2008
[Antiviral treatment of influenza in humans].
    Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:11

    Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Virus Replication; Virus Shedding; Zanamivir

2007
Influenza guideline for South Africa--update 2008.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2008, Volume: 98, Issue:3 Pt 2

    Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine; South Africa; Vaccination

2008
Antivirals for the treatment and prevention of epidemic and pandemic influenza.
    Influenza and other respiratory viruses, 2007, Volume: 1, Issue:1

    Topics: Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir

2007
Resistance characteristics of influenza to amino-adamantyls.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:2

    Topics: Adamantane; Amantadine; Amino Acid Sequence; Drug Resistance, Viral; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Ion Channels; Models, Molecular; Molecular Sequence Data; Mutation; Protein Stability; Protein Structure, Tertiary; Rimantadine; Sequence Homology, Amino Acid; Viral Matrix Proteins

2011
Flu channel drug resistance: a tale of two sites.
    Protein & cell, 2010, Volume: 1, Issue:3

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Genes, Viral; Humans; Influenza A virus; Influenza B virus; Ion Channels; Models, Molecular; Mutation; Protein Structure, Tertiary; Rimantadine; Viral Matrix Proteins; Viral Proteins

2010
[Research progress of anti-influenza virus agents].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3

    Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir

2010
Antiviral drugs for influenza.
    The Medical letter on drugs and therapeutics, 2012, Jan-09, Volume: 54, Issue:1381

    Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir

2012
Amantadine and rimantadine for influenza A in children and the elderly.
    The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1

    Topics: Adolescent; Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors; Young Adult

2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
    Annals of internal medicine, 2012, Apr-03, Volume: 156, Issue:7

    Topics: Administration, Inhalation; Administration, Oral; Amantadine; Antiviral Agents; Confounding Factors, Epidemiologic; Hospitalization; Humans; Influenza, Human; Oseltamivir; Rimantadine; Treatment Outcome; Zanamivir

2012
Antivirals--current trends in fighting influenza.
    Acta biochimica Polonica, 2014, Volume: 61, Issue:3

    Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Viral Matrix Proteins; Zanamivir

2014
Amantadine and rimantadine for influenza A in children and the elderly.
    The Cochrane database of systematic reviews, 2014, Nov-21, Issue:11

    Topics: Adolescent; Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors; Young Adult

2014
Inhibitors targeting the influenza virus hemagglutinin.
    Current medicinal chemistry, 2015, Volume: 22, Issue:11

    Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Hemagglutinin Glycoproteins, Influenza Virus; Neuraminidase; Orthomyxoviridae; Oseltamivir; Rimantadine; Zanamivir

2015

Trials

12 trial(s) available for amantadine and rimantadine

ArticleYear
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
    Antiviral research, 1985, Volume: Suppl 1

    Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases

1985
Chemotherapy of respiratory viruses.
    Advances in internal medicine, 1986, Volume: 31

    Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases

1986
Antiviral chemotherapy and chemoprophylaxis.
    Science (New York, N.Y.), 1985, Mar-15, Volume: 227, Issue:4692

    Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases

1985
Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
    Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:2

    Topics: Adamantane; Adult; Aged; Amantadine; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Mucus; Nasal Mucosa; Rimantadine

1985
Antiviral drugs 1983.
    The Medical clinics of North America, 1983, Volume: 67, Issue:5

    Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine

1983
Antiviral drugs today.
    The New Zealand medical journal, 1984, Dec-12, Volume: 97, Issue:769

    Topics: Acyclovir; Administration, Topical; Adolescent; Amantadine; Antiviral Agents; Chickenpox; Child; Clinical Trials as Topic; Encephalitis; Female; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Keratitis, Dendritic; Male; Rimantadine; Vidarabine

1984
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:3

    Topics: Adamantane; Adult; Amantadine; Central Nervous System; Digestive System; Humans; Kinetics; Middle Aged; Rimantadine; Sleep

1983
Successful treatment of naturally occurring influenza A/USSR/77 H1N1.
    JAMA, 1981, Mar-20, Volume: 245, Issue:11

    Topics: Adult; Amantadine; Central Nervous System; Clinical Trials as Topic; Double-Blind Method; Humans; Infant, Newborn; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Rimantadine

1981
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:1

    Topics: Adamantane; Adolescent; Adult; Amantadine; Central Nervous System; Chlorpheniramine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Rimantadine

1982
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    The New England journal of medicine, 1982, Sep-02, Volume: 307, Issue:10

    Topics: Adamantane; Adolescent; Adult; Amantadine; Clinical Trials as Topic; Humans; Infant, Newborn; Influenza A virus; Influenza, Human; Middle Aged; Patient Compliance; Random Allocation; Rimantadine

1982
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:2

    Topics: Adamantane; Adult; Amantadine; Central Nervous System Diseases; Gastrointestinal Diseases; Humans; Motor Skills; Rimantadine; Sleep Wake Disorders; Time Factors

1981
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinson Disease; Rimantadine; Severity of Illness Index

2005

Other Studies

192 other study(ies) available for amantadine and rimantadine

ArticleYear
Synthesis and antiviral activity of metabolites of rimantadine.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:7

    Topics: Adamantane; Animals; Antiviral Agents; Cell Line; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Rimantadine; Structure-Activity Relationship

1990
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
    Journal of medicinal chemistry, 1996, Aug-16, Volume: 39, Issue:17

    Topics: Adamantane; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Dogs; Enterovirus B, Human; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Reoviridae; Semliki forest virus; Sindbis Virus; Structure-Activity Relationship; Vaccinia virus; Vesicular stomatitis Indiana virus

1996
Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus A activity relationship study using a combination of NMR spectroscopy and molecular modeling.
    Bioorganic & medicinal chemistry letters, 1999, Dec-20, Volume: 9, Issue:24

    Topics: Animals; Antiviral Agents; Cell Line; Dogs; Influenza A virus; Magnetic Resonance Spectroscopy; Models, Molecular; Piperidines

1999
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Design and synthesis of bioactive adamantane spiro heterocycles.
    Bioorganic & medicinal chemistry letters, 2007, Aug-01, Volume: 17, Issue:15

    Topics: Adamantane; Animals; Antiprotozoal Agents; Antiviral Agents; Heterocyclic Compounds; Influenza A virus; Leishmania; Trypanosoma

2007
Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure.
    Bioorganic & medicinal chemistry, 2008, Sep-15, Volume: 16, Issue:18

    Topics: Animals; Antiviral Agents; Aza Compounds; Catalysis; Cell Line; DNA Viruses; Drug Resistance, Viral; Humans; Hydrogenation; Nucleosides; Palladium; Pyrimidine Nucleosides; RNA Viruses; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides

2008
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs.
    Bioorganic & medicinal chemistry, 2008, Dec-01, Volume: 16, Issue:23

    Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Dopamine; Influenza A virus; Inhibitory Concentration 50; Receptors, N-Methyl-D-Aspartate

2008
Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Bioorganic & medicinal chemistry, 2009, Feb-15, Volume: 17, Issue:4

    Topics: Adamantane; Animals; Antiviral Agents; Dogs; Humans; Influenza A Virus, H3N2 Subtype; Magnetic Resonance Spectroscopy; Molecular Structure; Piperidines; Rimantadine; Structure-Activity Relationship

2009
Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.
    Bioorganic & medicinal chemistry, 2009, Apr-15, Volume: 17, Issue:8

    Topics: Adamantane; Amines; Animals; Antiviral Agents; Cell Culture Techniques; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents

2009
Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
    Journal of medicinal chemistry, 2009, Apr-09, Volume: 52, Issue:7

    Topics: Amino Acids; Animals; Anti-HIV Agents; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Drug Resistance, Viral; Enterovirus B, Human; HIV Reverse Transcriptase; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Lymphocytes; Mice; Models, Molecular; Molecular Conformation; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones; Virus Replication

2009
Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Anti-Bacterial Agents; Antiviral Agents; Diazonium Compounds; Doxorubicin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Orthomyxoviridae; Teicoplanin

2009
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
    Bioorganic & medicinal chemistry, 2010, Jan-01, Volume: 18, Issue:1

    Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neurons; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis

2010
Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity.
    Bioorganic & medicinal chemistry letters, 2010, May-01, Volume: 20, Issue:9

    Topics: Anti-Bacterial Agents; Antiviral Agents; Catalysis; Copper; Doxorubicin; Humans; Influenza A Virus, H1N1 Subtype; Microbial Sensitivity Tests; Ristocetin

2010
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.
    Bioorganic & medicinal chemistry letters, 2010, Jul-15, Volume: 20, Issue:14

    Topics: Adamantane; Amino Acid Sequence; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Viral Matrix Proteins

2010
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Schiff Bases; Spectrophotometry, Infrared

2010
Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Adamantane; Alcohols; Amines; Animals; Antiviral Agents; Drug Design; Influenza A virus; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Trypanosoma brucei brucei

2010
4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:12

    Topics: Animals; Anti-Infective Agents; Benzenesulfonates; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Dogs; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses

2010
Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.
    Bioorganic & medicinal chemistry, 2012, Jan-15, Volume: 20, Issue:2

    Topics: Amines; Antiviral Agents; DNA Viruses; Humans; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei

2012
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Aminoquinolines; Animals; Antimalarials; Cell Line; DNA; Dogs; Heme; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Protoporphyrins; Pyrimidines; Structure-Activity Relationship; Viruses

2012
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Drug Resistance, Viral; Gram-Positive Bacteria; Herpesvirus 1, Human; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Isoindoles; Microbial Sensitivity Tests; o-Phthalaldehyde; Teicoplanin

2012
Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
    Bioorganic & medicinal chemistry, 2012, Dec-15, Volume: 20, Issue:24

    Topics: Adamantane; Amides; Animals; Antiviral Agents; Aza Compounds; Chickens; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Microwaves; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Virus Replication

2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013
Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
    Journal of medicinal chemistry, 2013, Apr-11, Volume: 56, Issue:7

    Topics: Antiviral Agents; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Mutation; Structure-Activity Relationship; Viral Matrix Proteins

2013
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies.
    European journal of medicinal chemistry, 2013, Volume: 66

    Topics: Antimalarials; Antiviral Agents; Cell Line; Chemistry Techniques, Synthetic; DNA; Heme; Humans; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship

2013
Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.
    European journal of medicinal chemistry, 2013, Volume: 67

    Topics: Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidinones; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses

2013
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
    Journal of medicinal chemistry, 2013, Nov-27, Volume: 56, Issue:22

    Topics: Amantadine; Animals; Antiviral Agents; Aza Compounds; Bridged-Ring Compounds; Dogs; Drug Design; Drug Resistance, Viral; Guanidines; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Mutation; Pyrrolidines; Structure-Activity Relationship; Viral Matrix Proteins

2013
Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Multiple, Viral; HEK293 Cells; Humans; Influenza A Virus, H1N1 Subtype; Ion Channels; Madin Darby Canine Kidney Cells; Mutation; Rimantadine; Viral Matrix Proteins

2014
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.
    ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12

    Topics:

2012
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
    Bioorganic & medicinal chemistry letters, 2014, Aug-01, Volume: 24, Issue:15

    Topics: Animals; Antiviral Agents; Binding Sites; Dogs; Dose-Response Relationship, Drug; Lipid Bilayers; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Structure-Activity Relationship; Teicoplanin

2014
A few atoms make the difference: synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives.
    European journal of medicinal chemistry, 2015, Apr-13, Volume: 94

    Topics: Anti-Bacterial Agents; Antiviral Agents; Chemistry Techniques, Synthetic; Circular Dichroism; Computer Simulation; Magnetic Resonance Spectroscopy; Orthomyxoviridae; Protein Conformation; Ristocetin; Structure-Activity Relationship; Teicoplanin

2015
New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
    European journal of medicinal chemistry, 2015, Volume: 96

    Topics: Animals; Antiviral Agents; Binding Sites; Cell Survival; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Influenza A virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mutation; Polycyclic Compounds; Structure-Activity Relationship; Viral Matrix Proteins

2015
1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Animals; Antiviral Agents; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; HIV-1; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil

2016
Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity.
    Bioorganic & medicinal chemistry letters, 2017, 05-15, Volume: 27, Issue:10

    Topics: Animals; Antiviral Agents; Camphor; Click Chemistry; Dogs; Ethanolamines; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Structure-Activity Relationship

2017
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.
    Journal of medicinal chemistry, 2017, 05-11, Volume: 60, Issue:9

    Topics: Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Influenza A virus; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Mutation; Patch-Clamp Techniques

2017
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
    European journal of medicinal chemistry, 2017, Jul-28, Volume: 135

    Topics: Antiviral Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proguanil; Respiratory Syncytial Viruses; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines

2017
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants.
    ACS medicinal chemistry letters, 2018, Mar-08, Volume: 9, Issue:3

    Topics:

2018
Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs.
    Bioorganic & medicinal chemistry, 2018, 07-23, Volume: 26, Issue:12

    Topics: Antiviral Agents; Cell Line; DNA Viruses; Drug Stability; Humans; Nucleosides; Organophosphonates; Prodrugs; RNA Viruses; Structure-Activity Relationship

2018
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Antiviral Agents; Aza Compounds; Dose-Response Relationship, Drug; Folic Acid Antagonists; Models, Molecular; Molecular Structure; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines

2018
Synthesis and
    MedChemComm, 2017, May-01, Volume: 8, Issue:5

    Topics:

2017
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin

2018
Synthesis of d-(+)-camphor-based
    MedChemComm, 2018, Dec-01, Volume: 9, Issue:12

    Topics:

2018
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
    European journal of medicinal chemistry, 2019, Dec-15, Volume: 184

    Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses

2019
Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
    Bioorganic & medicinal chemistry letters, 2019, 12-01, Volume: 29, Issue:23

    Topics: Camphor; Ethanolamines; Humans; Influenza, Human; Structure-Activity Relationship

2019
Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-
    Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2013, Volume: 22, Issue:4

    Topics:

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
[Prophylaxis of influenza. Vaccination and chemoprophylaxis].
    La Revue du praticien, 1992, Oct-01, Volume: 42, Issue:15

    Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine

1992
[Amantadine and rimantadine against influenza A].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1992, Jun-20, Volume: 112, Issue:16

    Topics: Amantadine; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Norway; Rimantadine

1992
Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.
    Virology, 1992, Volume: 190, Issue:1

    Topics: Amantadine; Animals; Biological Transport; Cell Line; Genes, Viral; Genetic Complementation Test; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins, Viral; Hydrogen-Ion Concentration; Influenza A virus; Mutation; Rimantadine; Viral Matrix Proteins

1992
Antivirals for the chemoprophylaxis and treatment of influenza.
    Seminars in respiratory infections, 1992, Volume: 7, Issue:1

    Topics: Administration, Intranasal; Administration, Oral; Amantadine; Drug Resistance; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Ribavirin; Rimantadine

1992
Prevention and control of influenza recommendations of the Immunization Practices Advisory Committee (ACIP).
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1991, May-24, Volume: 40, Issue:RR-6

    Topics: Adolescent; Adult; Aged; Amantadine; Child; Child, Preschool; Disease Outbreaks; Female; HIV Infections; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Pregnancy; Pregnancy Complications, Infectious; Rimantadine

1991
Antiviral therapy. New drugs and their uses.
    Postgraduate medicine, 1986, Volume: 80, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Common Cold; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Thymidine; Vidarabine; Virus Diseases; Zidovudine

1986
Antiviral drugs for common respiratory diseases. What's here, what's to come.
    Postgraduate medicine, 1988, Feb-01, Volume: 83, Issue:2

    Topics: Adult; Aged; Amantadine; Antiviral Agents; Child; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Interferons; Paramyxoviridae Infections; Pneumonia, Viral; Pregnancy; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Rimantadine; Virus Diseases

1988
[Prevention of influenza].
    Revue de l'infirmiere, 1989, Volume: 39, Issue:15

    Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine

1989
Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
    The Journal of infectious diseases, 1989, Volume: 159, Issue:3

    Topics: Adamantane; Amantadine; Animals; Antigens, Viral; Cell Line; Cytopathogenic Effect, Viral; Dogs; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Influenza A virus; Influenza, Human; Rimantadine; Viral Plaque Assay

1989
Interaction of the antivirus agents remantadine and amantadine with lipid membranes and the influence on the curvature of human red cells.
    General physiology and biophysics, 1986, Volume: 5, Issue:1

    Topics: Adamantane; Amantadine; Elasticity; Electron Spin Resonance Spectroscopy; Erythrocyte Deformability; Humans; Intracellular Membranes; Membrane Lipids; Rimantadine; Time Factors

1986
The influence of the antiviral drugs amantadine and rimantadine on erythrocyte and platelet membranes and its comparison with that of tetracaine.
    Biochemical pharmacology, 1987, Feb-15, Volume: 36, Issue:4

    Topics: Adamantane; Amantadine; Antiviral Agents; Blood Platelets; Cell Fractionation; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Hemagglutination, Viral; Humans; Osmotic Fragility; Platelet Aggregation; Rimantadine; Tetracaine

1987
Electrorotation--a new method for investigating membrane events during thrombocyte activation. Influence of drugs and osmotic pressure.
    Biochimica et biophysica acta, 1986, Sep-25, Volume: 861, Issue:1

    Topics: Adamantane; Amantadine; Blood Platelets; Calcimycin; Cell Membrane; Chlorpromazine; Electrochemistry; Humans; Light; Mathematics; Osmotic Pressure; Platelet Aggregation; Rimantadine; Scattering, Radiation; Thrombin

1986
[Influenza virus infection. Influenza preventive vaccination and chemoprevention].
    Medizinische Monatsschrift fur Pharmazeuten, 1988, Volume: 11, Issue:10

    Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Risk Factors

1988
Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11

    Topics: Adamantane; Administration, Oral; Amantadine; Animals; Biological Availability; Dogs; Dose-Response Relationship, Drug; Feces; Female; Gas Chromatography-Mass Spectrometry; Lung; Metabolic Clearance Rate; Mice; Orthomyxoviridae Infections; Rimantadine

1988
Transport of amantadine and rimantadine through the blood-brain barrier.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:2

    Topics: Adamantane; Amantadine; Animals; Biological Transport; Blood-Brain Barrier; Perfusion; Rats; Rats, Inbred Strains; Rimantadine

1988
Antiviral agents.
    Mayo Clinic proceedings, 1987, Volume: 62, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpes Simplex; Humans; Idoxuridine; Influenza A virus; Influenza, Human; Ribavirin; Rimantadine; Thymidine; Vidarabine; Viruses; Zidovudine

1987
[Capillary isotachophoresis--a new method in drug analysis. 3. Analytic capillary isotachophoresis for the determination of amantadine and rimantadine].
    Die Pharmazie, 1986, Volume: 41, Issue:7

    Topics: Adamantane; Amantadine; Capsules; Electrophoresis; Rimantadine; Spectrophotometry, Ultraviolet; Tablets

1986
Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl B

    Topics: Adamantane; Amantadine; Animals; Drug Resistance, Microbial; Influenza A virus; Influenza A Virus, H5N2 Subtype; Influenza Vaccines; Orthomyxoviridae Infections; Poultry; Poultry Diseases; Rimantadine; Vaccination

1986
Combinations of antiviral agents for treatment of influenza virus infections.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl B

    Topics: Amantadine; Animals; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Orthomyxoviridae Infections; Ribavirin; Rimantadine

1986
Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
    Bulletin of the World Health Organization, 1985, Volume: 63, Issue:1

    Topics: Adamantane; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine

1985
Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
    Journal of virology, 1985, Volume: 55, Issue:1

    Topics: Adamantane; Amantadine; Animals; Chickens; Drug Resistance, Microbial; Influenza A virus; Influenza in Birds; Rimantadine; Vaccination; Viral Vaccines

1985
Community-acquired lower respiratory tract infections. Prevention and cost-control strategies.
    The American journal of medicine, 1985, Jun-28, Volume: 78, Issue:6B

    Topics: Amantadine; Cost Control; Cross Infection; Humans; Influenza Vaccines; Influenza, Human; Pneumonia; Rimantadine; Sputum; Streptococcus pneumoniae; Vaccines

1985
[Action of antiviral substances on influenza viruses through the inhibition of neuraminidase production].
    Archiv fur experimentelle Veterinarmedizin, 1985, Volume: 39, Issue:3

    Topics: Adamantane; Amantadine; Animals; Chick Embryo; Culture Techniques; Fibroblasts; Influenza A virus; Neuraminidase; Rimantadine

1985
Evaluation of antiviral substances against influenza A virus strains by the haemadsorption reduction test.
    Acta virologica, 1980, Volume: 24, Issue:5

    Topics: Amantadine; Antiviral Agents; Deoxyglucose; Drug Evaluation, Preclinical; Hemadsorption Inhibition Tests; Influenza A virus; Microbiological Techniques; Ribavirin; Rimantadine

1980
Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
    Acta virologica, 1981, Volume: 25, Issue:6

    Topics: Adamantane; Amantadine; Drug Resistance, Microbial; Humans; Influenza A virus; Mutation; Rimantadine

1981
The effects of amantadine, rimantadine and levodopa on the frequency of fibrillation potentials in denervated muscle.
    Electroencephalography and clinical neurophysiology, 1984, Volume: 57, Issue:2

    Topics: Acetylcholine; Adamantane; Amantadine; Animals; Electromyography; Levodopa; Muscle Contraction; Muscle Denervation; Rats; Receptors, Cholinergic; Rimantadine

1984
Amantadine modulates phencyclidine binding site sensitivity in rat brain.
    Experientia, 1982, Aug-15, Volume: 38, Issue:8

    Topics: Amantadine; Animals; Brain; Olfactory Bulb; Phencyclidine; Rats; Receptors, Drug; Receptors, Phencyclidine; Rimantadine

1982
New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl A

    Topics: Amantadine; Antiviral Agents; Humans; Rimantadine

1984
Interaction of influenza virus proteins with planar bilayer lipid membranes. II. Effects of rimantadine and amantadine.
    Biochimica et biophysica acta, 1984, Dec-05, Volume: 778, Issue:2

    Topics: Adamantane; Amantadine; Dose-Response Relationship, Drug; Kinetics; Lipid Bilayers; Membrane Potentials; Phosphatidylcholines; Phospholipids; Rimantadine; Viral Matrix Proteins; Viral Proteins

1984
Influenza: prevention and therapy.
    Henry Ford Hospital medical journal, 1984, Volume: 32, Issue:2

    Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccination

1984
[Amantadine and riamantadine in the treatment of influenza].
    Recenti progressi in medicina, 1983, Volume: 74, Issue:3

    Topics: Adamantane; Amantadine; Humans; Influenza, Human; Rimantadine

1983
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
    Immunopharmacology, 1983, Volume: 6, Issue:4

    Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine

1983
Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:5

    Topics: Adamantane; Amantadine; Animals; Cilia; Cytopathogenic Effect, Viral; Epithelium; Ferrets; In Vitro Techniques; Influenza A virus; Rimantadine; Time Factors; Trachea; Virus Cultivation

1982
Toxicity of amantadine and rimantadine for the ciliated epithelium of ferret tracheal rings.
    The Journal of infectious diseases, 1981, Volume: 144, Issue:1

    Topics: Adamantane; Amantadine; Animals; Cilia; Ferrets; In Vitro Techniques; Rimantadine; Trachea

1981
Adamantine influenza and the adamantanes.
    Medical biology, 1981, Volume: 59, Issue:1

    Topics: Amantadine; Humans; Influenza, Human; Orthomyxoviridae; Rimantadine

1981
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
    Antiviral research, 1981, Volume: 1, Issue:3

    Topics: Adamantane; Adolescent; Adult; Age Factors; Amantadine; Antibodies, Viral; Double-Blind Method; Drug Evaluation; Female; Humans; Influenza A virus; Influenza, Human; Male; Rimantadine

1981
Plaque inhibition assay for drug susceptibility testing of influenza viruses.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:5

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Microbial Sensitivity Tests; Orthomyxoviridae; Ribavirin; Rimantadine; Time Factors; Viral Plaque Assay

1980
Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity.
    The Journal of general virology, 1994, Volume: 75 ( Pt 12)

    Topics: Amantadine; Animals; Arylsulfonates; Cell Line; Fluorescent Dyes; Gene Expression Regulation, Viral; Genetic Vectors; Hydrogen-Ion Concentration; Influenza A virus; Ion Channels; Liposomes; Molecular Weight; Nucleopolyhedroviruses; Phosphorylation; Protein Conformation; Protons; Recombinant Fusion Proteins; Rimantadine; Spodoptera; Viral Matrix Proteins

1994
ACIP updates recommendations for the use of antiviral agents in influenza. Advisory Committee on Immunization Practices.
    American family physician, 1995, Volume: 52, Issue:2

    Topics: Amantadine; Humans; Influenza, Human; Rimantadine

1995
Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1995, Apr-21, Volume: 44, Issue:RR-3

    Topics: Amantadine; Antiviral Agents; Humans; Immunization Schedule; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccines, Inactivated

1995
Influenza: prevention and control.
    Rhode Island medicine, 1994, Volume: 77, Issue:11

    Topics: Adolescent; Adult; Aged; Amantadine; Child; Child, Preschool; Female; Humans; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rhode Island; Rimantadine; Risk Factors

1994
Annualizing our approach to influenza.
    Hospital practice (Office ed.), 1995, Jan-15, Volume: 30, Issue:1

    Topics: Adult; Aged; Amantadine; Child; Diagnosis, Differential; Humans; Influenza Vaccines; Influenza, Human; Male; Rimantadine

1995
Therapeutic approaches of clinicians to influenza pandemic.
    European journal of epidemiology, 1994, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Aged; Amantadine; Child; Disease Outbreaks; Female; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Pregnancy; Rimantadine; Risk Factors; Vaccination

1994
Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
    Archives of internal medicine, 1995, Mar-13, Volume: 155, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amantadine; Base Sequence; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Molecular Sequence Data; Nursing Homes; Rimantadine; Treatment Failure; Washington

1995
Combined antiinfluenza activity of a plant preparation SHS-174 and amantadine derivatives.
    Acta virologica, 1993, Volume: 37, Issue:4

    Topics: Amantadine; Animals; Chick Embryo; Drug Interactions; Orthomyxoviridae; Plant Extracts; Rimantadine; Virus Replication

1993
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1994, Apr-01, Volume: 36, Issue:919

    Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases

1994
Determination of amantadine in human plasma by capillary gas chromatography using electron-capture detection following derivatization with pentafluorobenzoyl chloride.
    Journal of pharmaceutical and biomedical analysis, 1993, Volume: 11, Issue:8

    Topics: Administration, Oral; Adult; Amantadine; Benzoates; Chromatography, Gas; Humans; Hydrogen-Ion Concentration; Male; Reference Standards; Reproducibility of Results; Rimantadine; Sensitivity and Specificity; Therapeutic Equivalency; Toluene

1993
Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1996, May-03, Volume: 45, Issue:RR-5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Drug Interactions; Female; Humans; Immunization Programs; Immunization Schedule; Infant; Infection Control; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine; Risk Factors; United States; Vaccination; Vaccines, Inactivated

1996
ACIP issues recommendations for the prevention and control of influenza in the 1996-97 season.
    American family physician, 1996, Volume: 54, Issue:2

    Topics: Amantadine; Antiviral Agents; Contraindications; Humans; Immunization Programs; Influenza Vaccines; Influenza, Human; Premedication; Rimantadine; Seasons; United States

1996
Combination antiviral therapy for respiratory virus infections.
    Antiviral research, 1996, Volume: 29, Issue:1

    Topics: Amantadine; Animals; Antiviral Agents; Common Cold; Drug Therapy, Combination; Humans; Influenza, Human; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Rimantadine

1996
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1997, Apr-25, Volume: 46, Issue:RR-9

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Breast Feeding; Child; Child, Preschool; Contraindications; Cross Infection; Female; HIV Infections; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine; Risk Factors; Travel; United States; Vaccination; Vaccines, Inactivated

1997
Advisory Committee on Immunization Practices issues recommendations for the 1997-98 influenza season.
    American family physician, 1997, Volume: 56, Issue:1

    Topics: Amantadine; Antiviral Agents; Humans; Immunization Schedule; Influenza, Human; Rimantadine; United States; Viral Vaccines

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006

    Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases

1997
A new antiviral agent for influenza--is there a clinical niche?
    The New England journal of medicine, 1997, Sep-25, Volume: 337, Issue:13

    Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir

1997
Influenza: immunization/prophylaxis for children, adults, and older adults. CDC Advisory Committee on Immunization Practices.
    The Nurse practitioner, 1997, Volume: 22, Issue:11

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Female; Humans; Immunization Schedule; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine

1997
Outbreaks of influenza A and B in a highly immunized nursing home population.
    The Journal of family practice, 1997, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Nursing Homes; Orthomyxoviridae; Population Surveillance; Prospective Studies; Rimantadine; Vaccination; Wisconsin

1997
[Antiviral prophylaxis and treatment of influenza].
    Ugeskrift for laeger, 1998, Mar-09, Volume: 160, Issue:11

    Topics: Amantadine; Antiviral Agents; Haemophilus Vaccines; Humans; Influenza Vaccines; Influenza, Human; Rimantadine

1998
Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:4

    Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Models, Theoretical; Rimantadine; Treatment Outcome

1998
[Comparative analysis of effects of adapromine, midantan, and bromantane on the bioelectric activity of the rat brain].
    Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 125, Issue:2

    Topics: Amantadine; Animals; Brain; Central Nervous System Stimulants; Electroencephalography; Male; Rats; Rimantadine

1998
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1998, May-01, Volume: 47, Issue:RR-6

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Humans; Immunization Programs; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Polyradiculoneuropathy; Rimantadine; Vaccination; Vaccines, Inactivated

1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Adult; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Leukemia; Middle Aged; Opportunistic Infections; Rimantadine

1998
Long-term stability of the anti-influenza A compounds--amantadine and rimantadine.
    Antiviral research, 1998, Volume: 38, Issue:3

    Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Drug Stability; Humans; Influenza A virus; Influenza, Human; Rimantadine; Time Factors; Viral Plaque Assay

1998
[Report on the therapeutic use of rimantadine and amantadine].
    Revista cubana de medicina tropical, 1992, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Homes for the Aged; Hospitalization; Humans; Influenza, Human; Middle Aged; Rimantadine

1992
Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists.
    Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153

    Topics: Administration, Inhalation; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Orthomyxoviridae; Pyrans; Rimantadine; Sialic Acids; Time Factors; Zanamivir

1999
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1999, Apr-30, Volume: 48, Issue:RR-4

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost of Illness; Cross Infection; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Rimantadine; Risk Factors; Vaccination

1999
Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Adenosine Triphosphatases; Amantadine; Dose-Response Relationship, Drug; Endopeptidases; Hepacivirus; Protein Biosynthesis; Rimantadine; RNA Helicases; RNA-Dependent RNA Polymerase; Viral Matrix Proteins; Viral Proteins

2000
Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.
    Archives of internal medicine, 2000, May-22, Volume: 160, Issue:10

    Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Central Nervous System Diseases; Female; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Male; Neurologic Examination; Nursing Homes; Rimantadine; Risk Factors

2000
Flu-fighting options: decisions, decisions....
    Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12

    Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2000
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs.
    The Journal of general virology, 2001, Volume: 82, Issue:Pt 6

    Topics: Amantadine; Animals; Antigens, Viral; Antiviral Agents; Birds; Drug Resistance, Microbial; Europe; Genes, Viral; HN Protein; Hong Kong; Humans; Infant; Influenza A virus; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phylogeny; Rimantadine; Swine

2001
How to beat the flu: the latest options as a vaccine shortage looms.
    Consumer reports, 2000, Volume: 65, Issue:11

    Topics: Acetamides; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Device Approval; Drug Costs; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Risk Factors; Sialic Acids; United States; United States Food and Drug Administration

2000
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices.
    American family physician, 2001, Oct-01, Volume: 64, Issue:7

    Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Selection; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2001
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine

2002
Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.
    Electrophoresis, 2002, Volume: 23, Issue:2

    Topics: alpha-Cyclodextrins; Amantadine; Antiviral Agents; beta-Cyclodextrins; Cyclodextrins; Electric Conductivity; Electrophoresis, Capillary; Memantine; Rimantadine

2002
Influenza surveillance with rapid diagnostic tests.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, May-15, Volume: 34, Issue:10

    Topics: Acetamides; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Population Surveillance; Rimantadine; United States

2002
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2002, Apr-12, Volume: 51, Issue:RR-3

    Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Risk Factors; Sialic Acids; United States; Vaccination; Zanamivir

2002
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Oct-15, Volume: 99, Issue:21

    Topics: Amantadine; Animals; Antiviral Agents; Disease Outbreaks; Enzyme Inhibitors; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; History, 20th Century; Humans; Influenza A virus; Influenza, Human; Male; Mice; Mice, Inbred BALB C; Neuraminidase; Recombination, Genetic; Rimantadine; Viral Matrix Proteins; Virulence

2002
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
    Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1

    Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir

2003
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
    Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1

    Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir

2003
[Treatment of influenza in children].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:2

    Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2003
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.
    Arzneimittel-Forschung, 2004, Volume: 54, Issue:2

    Topics: Amantadine; Animals; Antiviral Agents; Chick Embryo; Drug Evaluation, Preclinical; Guanidines; Influenza A virus; Orthomyxoviridae Infections; Pyrans; Rimantadine; Sialic Acids; Survival Analysis; Zanamivir

2004
Avian influenza should be ruffling our feathers.
    The Lancet. Infectious diseases, 2004, Volume: 4, Issue:10

    Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease Outbreaks; Guanidines; Humans; Influenza in Birds; Influenza Vaccines; Influenza, Human; International Cooperation; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; World Health Organization; Zanamivir

2004
Antiviral drugs for prophylaxis and treatment of influenza.
    The Medical letter on drugs and therapeutics, 2004, Oct-25, Volume: 46, Issue:1194

    Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Rimantadine; Vaccination

2004
Antiviral drugs for prophylaxis and treatment of influenza.
    Obstetrics and gynecology, 2005, Volume: 105, Issue:2

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Prognosis; Rimantadine; Risk Assessment; Treatment Outcome; Vaccination

2005
I wish to comment on several points in the recent "Guidelines".
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 33, Issue:1

    Topics: Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Rimantadine; Treatment Outcome

2005
Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies.
    Biomedical chromatography : BMC, 2005, Volume: 19, Issue:9

    Topics: Amantadine; Animals; Chromatography, High Pressure Liquid; Fluorescent Dyes; Kinetics; Male; Mercaptoethanol; o-Phthalaldehyde; Rats; Rats, Wistar; Reproducibility of Results; Rimantadine

2005
Statement on travel, influenza, and prevention.
    Canada communicable disease report = Releve des maladies transmissibles au Canada, 2005, Mar-15, Volume: 31, Issue:ACS-2

    Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Travel

2005
Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.
    Journal of chromatographic science, 2005, Volume: 43, Issue:4

    Topics: Amantadine; Chromatography, Liquid; Dansyl Compounds; Melanins; Memantine; Reproducibility of Results; Rimantadine

2005
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Medical microbiology and immunology, 2006, Volume: 195, Issue:2

    Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanidines; Influenza A virus; Influenza in Birds; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2006
Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.
    Biomedical chromatography : BMC, 2006, Volume: 20, Issue:5

    Topics: 4-Chloro-7-nitrobenzofurazan; Amantadine; Binding, Competitive; Calibration; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Memantine; Phosphates; Reproducibility of Results; Rimantadine; Sodium Chloride

2006
Antiviral drugs for prophylaxis and treatment of influenza.
    The Medical letter on drugs and therapeutics, 2005, Nov-21, Volume: 47, Issue:1222

    Topics: Adolescent; Amantadine; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Neuraminidase; Rimantadine

2005
Antiviral resistance in influenza viruses--implications for management and pandemic response.
    The New England journal of medicine, 2006, Feb-23, Volume: 354, Issue:8

    Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Neuraminidase; Nucleic Acid Synthesis Inhibitors; Rimantadine; Viral Matrix Proteins; Virus Replication

2006
[Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
    Revue medicale suisse, 2006, Jan-25, Volume: 2, Issue:50

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Rimantadine

2006
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
    The Journal of infectious diseases, 2006, Jun-15, Volume: 193, Issue:12

    Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Asia; Birds; Drug Resistance, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Rimantadine

2006
Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections.
    Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2006, Volume: 68, Issue:2

    Topics: Amantadine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Humans; Neuraminidase; Orthomyxoviridae Infections; Ribavirin; Rimantadine

2006
Recommended composition of influenza virus vaccines for use in the 2007 influenza season.
    Releve epidemiologique hebdomadaire, 2006, Oct-13, Volume: 81, Issue:41

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine

2006
Amantadine may be lifesaving in severe influenza A.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Nov-15, Volume: 43, Issue:10

    Topics: Amantadine; Antiviral Agents; Dilatation; Disease Outbreaks; Humans; Influenza A virus; Influenza, Human; Rimantadine

2006
Antiviral management of seasonal and pandemic influenza.
    The Journal of infectious diseases, 2006, Nov-01, Volume: 194 Suppl 2

    Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Neuraminidase; Oseltamivir; Rimantadine; Seasons; Zanamivir

2006
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus].
    Pneumonologia i alergologia polska, 2006, Volume: 74, Issue:2

    Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir

2006
New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma.
    Journal of pharmaceutical and biomedical analysis, 2007, Sep-03, Volume: 44, Issue:5

    Topics: Amantadine; Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Male; Memantine; Molecular Structure; Rats; Rats, Sprague-Dawley; Rimantadine; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Temperature; Time Factors

2007
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
    The Journal of infectious diseases, 2007, Jul-15, Volume: 196, Issue:2

    Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Global Health; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Phylogeny; Rimantadine; Sentinel Surveillance

2007
Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
    Journal of medicinal chemistry, 2008, Mar-13, Volume: 51, Issue:5

    Topics: Adamantane; Amantadine; Animals; Parasitic Sensitivity Tests; Rimantadine; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei

2008
Influenza.
    Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:3

    Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mass Vaccination; Oseltamivir; Rimantadine; Zanamivir

2008
How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Journal of molecular graphics & modelling, 2008, Volume: 27, Issue:3

    Topics: Amantadine; Antiviral Agents; Binding Sites; Hydrogen Bonding; Influenza A virus; Ion Transport; Protons; Rimantadine; Solvents; Viral Matrix Proteins; Water

2008
Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
    Organic & biomolecular chemistry, 2008, Sep-07, Volume: 6, Issue:17

    Topics: Amantadine; Animals; Antiviral Agents; Drug Design; Influenza A Virus, H3N2 Subtype; Orthomyxoviridae Infections; Ribavirin; Rimantadine; Swine; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; Viral Matrix Proteins

2008
Antivirals and influenza: frequency of resistance.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:10 Suppl

    Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir

2008
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6

    Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication

2008
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir

2009
Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Journal of theoretical biology, 2009, Jul-07, Volume: 259, Issue:1

    Topics: Amantadine; Antiviral Agents; Binding Sites; Crystallography, X-Ray; Drug Resistance, Viral; Influenza A virus; Ion Channel Gating; Magnetic Resonance Spectroscopy; Models, Chemical; Rimantadine; Viral Matrix Proteins

2009
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.
    American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:4

    Topics: Amantadine; Antigens, CD1; Clathrin; Endocytosis; Enzyme Activation; Humans; In Vitro Techniques; NADPH Oxidases; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Rimantadine; Signal Transduction

2009
[Do we really need antiflu virus medication?].
    Medecine et maladies infectieuses, 2009, Volume: 39, Issue:9

    Topics: Amantadine; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Enzyme Inhibitors; Humans; Immunosuppression Therapy; Influenza, Human; Neuraminidase; Program Evaluation; Reproducibility of Results; Rimantadine

2009
Update: influenza activity - United States, August 30-October 31, 2009.
    MMWR. Morbidity and mortality weekly report, 2009, Nov-13, Volume: 58, Issue:44

    Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Outpatients; Pneumonia; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; United States

2009
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
    Obstetrics and gynecology, 2010, Volume: 115, Issue:4

    Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rimantadine

2010
Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:2

    Topics: Amantadine; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Hydrogen-Ion Concentration; Influenza A virus; Ion Channels; Micelles; Models, Molecular; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Protein Structure, Quaternary; Protons; Rimantadine; Viral Matrix Proteins

2011
Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.
    Antiviral research, 2010, Volume: 88, Issue:2

    Topics: Amantadine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Evolution, Molecular; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Iran; Molecular Sequence Data; Mutation; Neuraminidase; Phylogeny; Polymerase Chain Reaction; Rimantadine; Sequence Analysis, DNA; Viral Matrix Proteins

2010
Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
    PLoS pathogens, 2010, Sep-02, Volume: 6, Issue:9

    Topics: Amantadine; Antifungal Agents; Antiviral Agents; Blotting, Western; Electroporation; Hepacivirus; Hepatitis C; Humans; Hydrogen-Ion Concentration; Ion Channels; Kidney; Lipid Bilayers; Macrolides; Mutation; Protons; Rimantadine; RNA, Viral; Subcellular Fractions; Transcription, Genetic; Viral Proteins; Virion; Virus Internalization; Virus Replication

2010
Quantitative analysis of influenza M2 channel blockers.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:1

    Topics: Amantadine; Animals; Antiviral Agents; Blotting, Western; Chemistry, Pharmaceutical; Crystallography, X-Ray; Escherichia coli; Humans; Influenza A Virus, H1N1 Subtype; Mutation; Plasmids; Protein Structure, Tertiary; Rimantadine; Time Factors; Viral Matrix Proteins

2011
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
    Journal of the American Chemical Society, 2011, Jun-29, Volume: 133, Issue:25

    Topics: Adamantane; Amantadine; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Humans; Ion Channels; Mutation; Rimantadine; Static Electricity; Viral Matrix Proteins

2011
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
    The Journal of infectious diseases, 2011, Dec-15, Volume: 204, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir

2011
Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.
    Molecules (Basel, Switzerland), 2011, Dec-08, Volume: 16, Issue:12

    Topics: Amantadine; Antiviral Agents; Binding Sites; Drug Evaluation, Preclinical; Hydrogen Bonding; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Membrane Transport Modulators; Models, Molecular; Rimantadine; Structure-Activity Relationship; Thermodynamics; User-Computer Interface; Viral Matrix Proteins

2011
The involvement of a Na⁺- and Cl⁻-dependent transporter in the brain uptake of amantadine and rimantadine.
    Molecular pharmaceutics, 2012, Apr-02, Volume: 9, Issue:4

    Topics: Amantadine; Amino Acid Transport Systems; Animals; Blood-Brain Barrier; Blotting, Western; Brain; Humans; Mice; Rimantadine

2012
Determination of amantadine and rimantadine using a sensitive fluorescent probe.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2012, Volume: 98

    Topics: Amantadine; Analgesics, Non-Narcotic; Antiviral Agents; Fluorescent Dyes; Limit of Detection; Rimantadine; Spectrometry, Fluorescence

2012
Rimantadine and 2-adamantanamine elicit local anesthesia to cutaneous nociceptive stimuli in a rat model.
    Fundamental & clinical pharmacology, 2014, Volume: 28, Issue:2

    Topics: Amantadine; Anesthesia, Local; Anesthetics, Local; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Molecular Structure; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reflex; Rimantadine; Skin

2014
Exploring the proton conductance and drug resistance of BM2 channel through molecular dynamics simulations and free energy calculations at different pH conditions.
    The journal of physical chemistry. B, 2013, Jan-31, Volume: 117, Issue:4

    Topics: Amantadine; Drug Resistance, Viral; Hydrogen-Ion Concentration; Molecular Dynamics Simulation; Protons; Rimantadine; Structure-Activity Relationship; Thermodynamics; Viral Proteins

2013
Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:8

    Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Dogs; Drug Carriers; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Orthomyxoviridae Infections; Polyglutamic Acid; Polymers; Rimantadine

2013
Determination of amantadine and rimantadine in chicken muscle by QuEChERS pretreatment method and UHPLC coupled with LTQ Orbitrap mass spectrometry.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013, Nov-01, Volume: 938

    Topics: Amantadine; Animals; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Least-Squares Analysis; Limit of Detection; Mass Spectrometry; Meat; Muscle, Skeletal; Reproducibility of Results; Rimantadine

2013
The effect of intravenous sulfobutylether7 -β-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:4

    Topics: Amantadine; Animals; beta-Cyclodextrins; Drug Interactions; Erythrocytes; Injections, Intravenous; Male; Memantine; Models, Biological; Protein Binding; Rats, Sprague-Dawley; Rimantadine

2015
The influenza viruses.
    The Ceylon medical journal, 2015, Volume: 60, Issue:1

    Topics: Amantadine; Animals; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Pandemics; Rimantadine; Zoonoses

2015
Investigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocket.
    European biophysics journal : EBJ, 2016, Volume: 45, Issue:1

    Topics: Amantadine; Amino Acid Sequence; Amino Acid Substitution; Binding Sites; Molecular Docking Simulation; Molecular Sequence Data; Protein Binding; Rimantadine; Viral Matrix Proteins

2016
Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.
    Journal of leukocyte biology, 2016, Volume: 99, Issue:5

    Topics: Amantadine; Apoptosis; Caspase 1; Dendritic Cells; Humans; Imidazoles; Inflammasomes; Influenza A virus; Interferons; Interleukin-1; Ion Transport; Ions; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Rimantadine; Signal Transduction; Toll-Like Receptors; Up-Regulation

2016
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    Antiviral research, 2016, Volume: 129

    Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rimantadine; Severe Acute Respiratory Syndrome; Texas; Virus Replication

2016
[Determination of amantadine and rimantadine residues in egg and chicken samples by dispersive solid phase extraction purification-ultra high performance liquid chromatography-tandem mass spectrometry].
    Se pu = Chinese journal of chromatography, 2015, Volume: 33, Issue:11

    Topics: Amantadine; Animals; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Eggs; Food Contamination; Meat; Rimantadine; Solid Phase Extraction; Tandem Mass Spectrometry

2015
Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.
    Biophysical journal, 2016, 06-07, Volume: 110, Issue:11

    Topics: Amantadine; Antiviral Agents; Blotting, Western; Genotype; HEK293 Cells; Hemadsorption; Hepacivirus; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Patch-Clamp Techniques; Recombinant Proteins; Rimantadine; Transfection; Viral Proteins

2016
Chromatography column comparison and rapid pretreatment for the simultaneous analysis of amantadine, rimantadine, acyclovir, ribavirin, and moroxydine in chicken muscle by ultra high performance liquid chromatography and tandem mass spectrometry.
    Journal of separation science, 2016, Volume: 39, Issue:20

    Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Biguanides; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Meat; Morpholines; Ribavirin; Rimantadine; Tandem Mass Spectrometry

2016
Preparation of a monoclonal antibody against amantadine and rimantadine and development of an indirect competitive enzyme-linked immunosorbent assay for detecting the same in chicken muscle and liver.
    Journal of pharmaceutical and biomedical analysis, 2017, Jan-30, Volume: 133

    Topics: Amantadine; Animals; Antibodies, Monoclonal; Chickens; Drug Residues; Enzyme-Linked Immunosorbent Assay; Limit of Detection; Liver; Muscles; Rimantadine

2017
Dispersive micro solid phase extraction of amantadine, rimantadine and memantine in chicken muscle with magnetic cation exchange polymer.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2017, Apr-15, Volume: 1051

    Topics: Adsorption; Amantadine; Animals; Antiviral Agents; Cations; Chickens; Chromatography, High Pressure Liquid; Dopamine Agents; Food Contamination; Limit of Detection; Magnets; Mass Spectrometry; Memantine; Muscles; Polymers; Poultry; Rimantadine; Solid Phase Extraction

2017
Accounting for apparent deviations between calorimetric and van't Hoff enthalpies.
    Biochimica et biophysica acta. General subjects, 2018, Volume: 1862, Issue:3

    Topics: Algorithms; Amantadine; beta-Cyclodextrins; Calorimetry; Energy Transfer; Hot Temperature; Kinetics; Rimantadine; Thermodynamics

2018
Simultaneous determination of amantadine and rimantadine in feed by liquid chromatography-Qtrap mass spectrometry with information-dependent acquisition.
    Analytical and bioanalytical chemistry, 2018, Volume: 410, Issue:22

    Topics: Amantadine; Animal Feed; Animals; Antiviral Agents; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Food Contamination; Hazard Analysis and Critical Control Points; Limit of Detection; Mass Spectrometry; Rimantadine; Solid Phase Extraction

2018
Channel activity of mirror-image M2 proton channel of influenza A virus is blocked by achiral or chiral inhibitors.
    Protein & cell, 2019, Volume: 10, Issue:3

    Topics: Amantadine; Antiviral Agents; Biological Transport; Hydrogen; Influenza A virus; Ion Channels; Rimantadine; Viral Matrix Proteins

2019
Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Adamantane; Amantadine; Antiviral Agents; Cells, Cultured; Drug Design; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Rimantadine; Viral Matrix Proteins; Viral Proteins

2018
Increased Dissociation of Adamantanamines in Influenza A M2 S31N with Partial Block by Rimantadine.
    Biophysical journal, 2020, 11-03, Volume: 119, Issue:9

    Topics: Amantadine; Antiviral Agents; Dissociative Disorders; Humans; Influenza, Human; Rimantadine; Viral Matrix Proteins

2020
Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    The Journal of general virology, 2021, Volume: 102, Issue:3

    Topics: Amantadine; Amino Acid Sequence; Antiviral Agents; Cell Survival; HEK293 Cells; Hepacivirus; Humans; Patch-Clamp Techniques; Rimantadine; Viral Proteins; Virus Assembly; Virus Release

2021
Development of a molecularly imprinted microspheres-based microplate fluorescence method for detection of amantadine and rimantadine in chicken.
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2021, Volume: 38, Issue:7

    Topics: Amantadine; Animals; Chickens; Microspheres; Molecular Imprinting; Molecular Structure; Muscles; Rimantadine; Spectrometry, Fluorescence

2021
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
    Viruses, 2021, 10-15, Volume: 13, Issue:10

    Topics: A549 Cells; Adenosine Monophosphate; Alanine; Amantadine; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Denmark; Drug Repositioning; Humans; Ion Channels; Memantine; Rimantadine; SARS-CoV-2; Vero Cells

2021
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
    Communications biology, 2021, 12-01, Volume: 4, Issue:1

    Topics: Amantadine; Amiloride; Antiviral Agents; Ion Channels; Rimantadine; SARS-CoV-2; Viral Proteins

2021
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
    Journal of virology, 2022, 09-28, Volume: 96, Issue:18

    Topics: Amantadine; Antiviral Agents; Autophagy; Cell Line; Hepatitis A; Hepatitis A Antibodies; Hepatitis A virus; Humans; Proteomics; Rimantadine; Virus Replication

2022
[Determination of amantadine, rimantadine and dimethylamantadine residues in poultry by ultra-performance liquid chromatography-tandem mass spectrometry].
    Wei sheng yan jiu = Journal of hygiene research, 2023, Volume: 52, Issue:2

    Topics: Amantadine; Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Food Contamination; Poultry; Rimantadine; Tandem Mass Spectrometry

2023
Metabolic profiling to evaluate the impact of amantadine and rimantadine on the secondary metabolism of a model organism.
    Scientific reports, 2023, 10-05, Volume: 13, Issue:1

    Topics: Adamantane; Amantadine; Metabolic Clearance Rate; Rimantadine; Secondary Metabolism

2023